Overall | No lung injury | Any lung injury | Severe lung injury | ||
---|---|---|---|---|---|
23996 | 10624 | 13372 | 338 | ||
Age mean (SD) | 51.62 (16.46) | 47.01 (16.27) | 55.28 (15.68) | 61.70 (15.17) | |
Age | 18–30 | 2572 (10.7) | 1801 (17.0) | 771 (5.8) | 6 (1.8) |
categories (%) | 31-40 | 4490 (18.7) | 2484 (23.4) | 2006 (15.0) | 26 (7.7) |
41–50 | 4437 (18.5) | 2075 (19.5) | 2362 (17.7) | 53 (15.7) | |
51–60 | 4664 (19.4) | 1816 (17.1) | 2848 (21.3) | 67 (19.8) | |
60+ | 7833 (32.6) | 2448 (23.0) | 5385 (40.3) | 186 (55.0) | |
Sex (%) | Female | 15577 (64.9) | 6974 (65.6) | 8603 (64.3) | 190 (56.2) |
Male | 8419 (35.1) | 3650 (34.4) | 4769 (35.7) | 148 (43.8) | |
Vaccination | Non-vaccinated | 12708 (53.0) | 4454 (41.9) | 8254 (61.7) | 257 (76.0) |
status | One-dose Gam-COVID-Vac | 437 (1.8) | 293 (2.8) | 144 (1.1) | 1 (0.3) |
Two-dose Gam-COVID-Vac | 6766 (28.2) | 3631 (34.2) | 3135 (23.4) | 52 (15.4) | |
Three-dose Gam-COVID-Vac | 1947 (8.1) | 1198 (11.3) | 749 (5.6) | 11 (3.3) | |
EpiVacCorona | 314 (1.3) | 104 (1.0) | 210 (1.6) | 5 (1.5) | |
CoviVac | 821 (3.4) | 421 (4.0) | 400 (3.0) | 4 (1.2) | |
No vaccination date | 357 (1.5) | 223 (2.1) | 134 (1.0) | 2 (0.6) | |
Vaccine name is not reported | 425 (1.8) | 205 (1.9) | 220 (1.6) | 2 (0.6) | |
Partially vaccinated | 171 (0.7) | 66 (0.6) | 105 (0.8) | 4 (1.2) | |
Other vaccines | 50 (0.2) | 29 (0.3) | 21 (0.2) | 0 (0.0) | |
Period (%) | Delta surge | ||||
(Oct 1, 2021–Jan 9, 2022) | 13394 (55.8) | 4141 (39.0) | 9253 (69.2) | 244 (72.2) | |
Omicron surge | |||||
(Jan 10, 2022–Apr 28, 2022) | 10602 (44.2) | 6483 (61.0) | 4119 (30.8) | 94 (27.8) | |
Triage | 1 | 15689 (65.4) | 7266 (68.4) | 8423 (63.0) | 210 (62.1) |
Centre (%) | 2 | 8307 (34.6) | 3358 (31.6) | 4949 (37.0) | 128 (37.9) |